ATE410513T1 - 'patched-2' protein aus wirbeltieren - Google Patents

'patched-2' protein aus wirbeltieren

Info

Publication number
ATE410513T1
ATE410513T1 AT99945688T AT99945688T ATE410513T1 AT E410513 T1 ATE410513 T1 AT E410513T1 AT 99945688 T AT99945688 T AT 99945688T AT 99945688 T AT99945688 T AT 99945688T AT E410513 T1 ATE410513 T1 AT E410513T1
Authority
AT
Austria
Prior art keywords
patched
vertebrates
protein
immunoadhesins
ests
Prior art date
Application number
AT99945688T
Other languages
English (en)
Inventor
SAUVAGE Frederic DE
David Carpenter
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22032676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE410513(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE410513T1 publication Critical patent/ATE410513T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
AT99945688T 1998-04-15 1999-04-02 'patched-2' protein aus wirbeltieren ATE410513T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/060,939 US6709838B1 (en) 1998-04-15 1998-04-15 Nucleic acid encoding patched-2

Publications (1)

Publication Number Publication Date
ATE410513T1 true ATE410513T1 (de) 2008-10-15

Family

ID=22032676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99945688T ATE410513T1 (de) 1998-04-15 1999-04-02 'patched-2' protein aus wirbeltieren

Country Status (13)

Country Link
US (1) US6709838B1 (de)
EP (1) EP1071779B1 (de)
JP (2) JP4693237B2 (de)
AT (1) ATE410513T1 (de)
AU (1) AU765918B2 (de)
CA (1) CA2323572C (de)
CY (1) CY1108619T1 (de)
DE (1) DE69939694D1 (de)
DK (1) DK1071779T3 (de)
ES (1) ES2316192T3 (de)
IL (3) IL138585A0 (de)
PT (1) PT1071779E (de)
WO (1) WO1999053058A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803393D0 (sv) * 1998-10-06 1998-10-06 Karolinska Innovations Ab A novel component in the hedgehog signalling pathway
GB9908798D0 (en) * 1999-04-16 1999-06-09 Pharmacia & Upjohn Spa Human homologues of fused gene
AU2429201A (en) * 1999-12-10 2001-06-18 General Hospital Corporation, The Methods to stimulate insulin production by pancreatic beta-cells
SE0000345D0 (sv) * 2000-02-03 2000-02-03 Karolinska Innovations Ab New matter
EP1229046A3 (de) * 2001-01-30 2004-02-25 Aeomica, Inc. Humanes patched-ähnliches Protein, dass in Testis exprimiert ist

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
WO1995018856A1 (en) 1993-12-30 1995-07-13 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing hedgehog-like proteins
US6027882A (en) 1994-10-07 2000-02-22 The Regents Of The University Of California Patched genes and their use for diagnostics
CA2201887C (en) 1994-10-07 2009-04-14 Matthew P. Scott Patched genes and their use
US6051400A (en) 1997-05-23 2000-04-18 Smithkline Beecham Plc Patched-2 polypeptides and polynucleotides
WO1999029854A1 (en) 1997-12-08 1999-06-17 Ontogeny, Inc. Human patched genes and proteins, and uses related thereto
US6022708A (en) 1998-02-26 2000-02-08 Genentech, Inc. Fused
SE9803393D0 (sv) * 1998-10-06 1998-10-06 Karolinska Innovations Ab A novel component in the hedgehog signalling pathway

Also Published As

Publication number Publication date
EP1071779B1 (de) 2008-10-08
JP2002511263A (ja) 2002-04-16
CA2323572A1 (en) 1999-10-21
DK1071779T3 (da) 2009-02-16
IL138585A0 (en) 2001-10-31
CA2323572C (en) 2011-10-18
IL138585A (en) 2010-11-30
JP4693237B2 (ja) 2011-06-01
EP1071779A1 (de) 2001-01-31
ES2316192T3 (es) 2009-04-01
CY1108619T1 (el) 2014-04-09
JP2010046077A (ja) 2010-03-04
WO1999053058A1 (en) 1999-10-21
IL205793A (en) 2015-01-29
US6709838B1 (en) 2004-03-23
DE69939694D1 (de) 2008-11-20
AU5265799A (en) 1999-11-01
AU765918B2 (en) 2003-10-02
PT1071779E (pt) 2009-01-13

Similar Documents

Publication Publication Date Title
ZA991525B (en) Vertebrate fused.
CA2174529A1 (en) Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof
ATE371727T1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
ATE319818T1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DK1133565T3 (da) Generering af specifikke bindingspartnere til (poly)peptider, som der kodes for af genomiske DNA-fragmenter eller EST'er
RS49990B (sr) Dnk sekvence vezane za kukuruzni transformant pv-zmgt 32 (nk 603) i preparati i metode za njegovu detekciju
BR9206578A (pt) Seqüência de DNA sintético tendo melhorada atividade inseticida em milho.
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
DK1265914T3 (da) WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
WO1996015144A3 (en) Chromosome 21 gene marker, compositions and methods using same
DK1064376T3 (da) GFR-alpha3 og dets anvendelser
ATE450603T1 (de) Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
CY1108619T1 (el) Πρωτεϊνη σπονδυλωτων patched-2
WO1999027098A3 (en) A-33 related antigens and their pharmacological uses
EP1117779A4 (de) -i(MORAXELLA CATARRHALIS) PrPTEIN; NUKLEINSAÜRESEQUENZ UND ANWENDUNGEN
DE69417223D1 (de) Ein menschlicher t-zell rezeptor der protein g-gekoppelte rezeptor familie
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
PT773999E (pt) Receptor orfao or-1 pertencente a familia de receptores nucleares
WO2002102847A1 (fr) Nouveau ligand et son adn
EP1140968A4 (de) Dna-moleküle kodierende spleissvarianten des humanen melanocortin-1-rezeptorproteins
WO2000040607A3 (en) Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
CA2244928A1 (en) Dna coding for serine/threonine kinase
WO2000065025A3 (en) Dna molecules encoding human endothelin converting enzyme 3
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1071779

Country of ref document: EP